Health Care [ 8/12 ] | Health Care Equipment & Supplies [ 51/74 ]
NASDAQ | Common Stock
NanoVibronix, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance.
Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.
The company also offers UroShield Ultra, which is designed to prevent bacterial colonization and biofilm formation in urinary catheters; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures.
In addition, it provides PainShield MD, a single patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; PainShield Plus, a dual patch-based therapeutic ultrasound technology; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing.
The company sells its products directly to patients, as well as through distributor agreements in the United States, Europe, Australia, Israel, New Zealand, and internationally.
NanoVibronix, Inc. was incorporated in 2003 and is based in Tyler, Texas.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 20, 25 | -3.98 Decreased by -1.60 K% | - |
| Feb 26, 25 | -4.51 Decreased by -3.18% | - |
| Nov 11, 24 | -0.36 Increased by +15.72% | - |
| Aug 14, 24 | -0.25 Increased by +61.76% | - |
| May 15, 24 | -0.23 Increased by +64.73% | - |
| Feb 28, 24 | -4.37 Decreased by -13.81% | - |
| Nov 13, 23 | -0.42 Decreased by -1.14 K% | - |
| Aug 11, 23 | -0.65 Decreased by -1.19 K% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | N/A Decreased by -100.00% | N/A Increased by +100.00% | - - |
| Dec 31, 24 | 444.00 K Decreased by -62.28% | -1.43 M Decreased by -76.01% | Decreased by -322.30% Decreased by -366.60% |
| Sep 30, 24 | 376.00 K Decreased by -17.90% | -998.00 K Decreased by -37.28% | Decreased by -265.43% Decreased by -67.21% |
| Jun 30, 24 | 817.00 K Increased by +177.89% | -688.00 K Increased by +35.94% | Decreased by -84.21% Increased by +76.95% |
| Mar 31, 24 | 921.00 K Increased by +160.17% | -588.00 K Increased by +46.40% | Decreased by -63.84% Increased by +79.40% |
| Dec 31, 23 | 1.18 M Increased by +1.25 K% | -813.00 K Increased by +60.51% | Decreased by -69.07% Decreased by -103.42% |
| Sep 30, 23 | 458.00 K Increased by +372.16% | -727.00 K Increased by +23.87% | Decreased by -158.73% Increased by +83.88% |
| Jun 30, 23 | 294.00 K Decreased by -39.38% | -1.07 M Increased by +17.51% | Decreased by -365.31% Decreased by -36.08% |